NCT07218003 2026-03-23
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
Rondo Therapeutics
Phase 1 Enrolling by invitation
Clinical Trials
29 trialsNCT07374835 2026-01-29
MLA-BMI-LLE
Tongji Hospital
Phase NA Enrolling by invitation
NCT07325682 2026-01-08
PETCVOCC
Oncology Center,Ministry Of Heath,Uzbekistan
Phase NA Enrolling by invitation
NCT07106359 2026-01-07
Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome
University of Alabama at Birmingham
Phase NA Enrolling by invitation
NCT07316361 2026-01-07
GYNORYLAQâ„¢
Biogenea Pharmaceuticals Ltd.
Phase EARLY_PHASE1 Enrolling by invitation
NCT07186530 2025-10-30
Offering HPV Self-Collection in Novel Healthcare Settings to Improve Uptake of Cervical Cancer Screening
Mayo Clinic
Phase NA Enrolling by invitation
NCT03544983 2025-10-29
Genetic Education in BRCA Families
Georgetown University
Phase NA Enrolling by invitation
NCT06942286 2025-09-17
Primary HPV Self-Collection in Indonesia
Dharmais National Cancer Center Hospital
Phase NA Enrolling by invitation
NCT07059819 2025-08-13
Local Hyperthermia for the Treatment of Cervical Persistent High-risk Infection
First Hospital of China Medical University
Phase NA Enrolling by invitation
NCT06914726 2025-08-05
PC-CDS
HealthPartners Institute
Phase NA Enrolling by invitation
NCT07078409 2025-07-22
Clinician Nudge to Referral of Adnexal Masses to Gynecologic Oncology
Abramson Cancer Center at Penn Medicine
Phase NA Enrolling by invitation
NCT07058753 2025-07-10
PREHONED
Medical University of Silesia
Phase NA Enrolling by invitation
NCT07023601 2025-06-17
VULCA-NODE
Hospital Universitario La Paz
Phase NA Enrolling by invitation
NCT06786091 2025-06-05
Late Side-effects After Cervical Cancer Treatment - Prevention and Treatment
St. Olavs Hospital
Phase NA Enrolling by invitation
NCT04165460 2025-05-28
Effect of Two Cognitive-Behavioral Interventions on Cervical Cancer Patients
National Institute of CancerologÃa
Phase NA Enrolling by invitation
NCT06943547 2025-04-29
IMPROVE
University of Puerto Rico Comprehensive Cancer Center
Phase NA Enrolling by invitation
NCT06915610 2025-04-23
JANUS
Instituto de Saude Publica da Universidade do Porto
Phase NA Enrolling by invitation
NCT06931184 2025-04-17
FALCON
Tampere University Hospital
Phase NA Enrolling by invitation
NCT06786780 2025-03-26
ECCO
Chongqing University Cancer Hospital
Phase 2 Enrolling by invitation
NCT04915495 2025-03-21
The Use of the LuViva Advanced Cervical Scan to Identify Women at High-Risk for Cervical Neoplasia
Guided Therapeutics
Phase NA Enrolling by invitation
NCT05231993 2025-03-19
Clinical Triage and Treatment of Atypical Glandular Cells (AGC) Detected in Screening
Karolinska Institutet
Phase NA Enrolling by invitation
NCT04755517 2025-01-13
HPV400
Tampere University Hospital
Phase NA Enrolling by invitation
NCT06755515 2025-01-01
A Phase Ⅱ/Ⅲ Study of Rulonilimab Plus Chemotherapy± Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer
Shandong New Time Pharmaceutical Co., LTD
Phase 2/3 Enrolling by invitation
NCT05524480 2024-12-12
Accelerating the Implementation of a Breast and Cervical Cancer Screening and HPV Vaccination Intervention
The University of Texas Health Science Center, Houston
Phase NA Enrolling by invitation
NCT06714084 2024-12-03
CNCMT
Hubei Cancer Hospital
Phase NA Enrolling by invitation
NCT06525870 2024-11-14
Trichlosil
Department of Medical Services Ministry of Public Health of Thailand
Phase 2 Enrolling by invitation
NCT06647992 2024-10-18
Effect of Nurse Navigation Program on Cervical Cancer Screening Behaviour of the Women Aged 30-65
Saglik Bilimleri Universitesi
Phase NA Enrolling by invitation
NCT05528237 2022-09-06
ACCESS
University of Washington
Phase NA Enrolling by invitation
NCT04361370 2021-04-19
OPEB-01
Yonsei University
Phase 2 Enrolling by invitation